MBP 3.23% 3.0¢ metabolic pharmaceuticals limited

mbp's new competitor ???????, page-3

  1. 13,013 Posts.
    lightbulb Created with Sketch. 99
    Agreed tbowan. It's clearly centrally acting with actions at the satiety centre and probably at other sites in the CNS as the claimed aphrodisiac action would suggest. A good deal of trialling will be required. You're also correct in highlighting the difference in mechanism of action. The hoodia supresses appetite whereas the MBP product which is a fragment of our growth hormone enhances fat metabolism. There would be quite different applications for each drug.
 
watchlist Created with Sketch. Add MBP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.